leisure time -WSS

leisure time

author：leisure time 2025-10-01 00:46:12 - browse：75355

a photo of the federal trade commission building — Alex Brandon/AP

The federal government is suing to block a proposed hospital deal in North Carolina, alleging it would hand control of over 65% of the inpatient market in the region to a single provider.

Novant Health’s proposed acquisition of two nearby hospitals is precisely the kind of case antitrust experts would expect the Federal Trade Commission to take on because it would make an already large regional player, Novant, even more powerful. And even though smaller deals like this get less attention than huge, 100-plus hospital mergers, they can still drive up people’s insurance premiums and medical bills.

In this case, Novant, a nonprofit system with $7.6 billion in 2022 revenue, plans to buy two hospitals in the same county from the for-profit chain Community Health Systems for $320 million. The two hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only about a 25-minute drive from one another. A Novant spokesperson called the FTC’s position flawed and said the system will pursue available legal responses. CHS spokesperson Tomi Galin wrote in an email that a judge will make the final determination on whether the transaction can proceed and thanked staff for continuing to deliver quality care during the regulatory process.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： The Readout: Lenmeldy, GLP

hotspot

focus

WSS

Readout LOUD podcast: mifepristone case, GLP

Primary care physicians play key roles in Alzheimer's management

There's no autism epidemic. It's an autism diagnosis epidemic

Supreme Court mifepristone arguments center on docs' right to sue

Industry veterans launch new biotech VC with $310M

Readout LOUD podcast: mifepristone case, GLP

hotspot

leisure time

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Tori Bowie and the unacceptable rates of Black maternal death

Readout LOUD podcast: How biotech is using artificial intelligence

Sports medicine is finally prioritizing gender equality

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Industry veterans launch new biotech VC with $310M

Activists slam private health insurers over coverage restrictions

What we’ve learned from the Aduhelm mess

Wikipedia

For Medicare Advantage, Democrats want stronger protections around AI

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

BioAge raises $170M for combination therapy with Zepbound

FDA's naming rule on biosimilars has undermined competition

Gilead might be held responsible for not developing a drug

Covid vaccine financial winners and losers, from Pfizer to Novavax

hotspot

hotspot

focus

hotspot